Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.25 USD | +0.39% |
|
-2.05% | +13.49% |
| Capitalization | 48.7B 41.43B 38.68B 36.29B 67.1B 4,393B 73.06B 451B 175B 2,075B 183B 179B 7,561B | P/E ratio 2025 * |
37x | P/E ratio 2026 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise value | 45.41B 38.63B 36.07B 33.84B 62.57B 4,096B 68.12B 420B 163B 1,935B 170B 167B 7,050B | EV / Sales 2025 * |
7.53x | EV / Sales 2026 * | 6.69x |
| Free-Float |
89.32% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.40% | ||
| 1 week | -2.05% | ||
| Current month | -3.06% | ||
| 1 month | -1.34% | ||
| 3 months | +7.70% | ||
| 6 months | +11.33% | ||
| Current year | +13.49% |
| 1 week | 83.08 |  | 87.89 |
| 1 month | 83.08 | | 87.89 |
| Current year | 65.94 | | 87.89 |
| 1 year | 65.94 | | 87.89 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 24.07 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 11/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 58 | 01/01/2014 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 61 | 10/02/2015 |
| Director/Board Member | 57 | 11/05/2023 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.46% | 51 M€ | -2.83% | - |
| 2.34% | 26 M€ | +11.07% | - |
| 1.17% | 27 M€ | +0.70% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.39% | -2.05% | +13.83% | +11.55% | 48.7B | |
| +0.58% | +0.49% | +8.18% | +1.85% | 216B | |
| -1.76% | -3.94% | +0.49% | +99.47% | 197B | |
| +0.41% | +1.98% | -1.61% | -15.31% | 163B | |
| -1.00% | -5.99% | +1.44% | +94.92% | 137B | |
| +1.04% | +2.37% | -19.30% | -13.27% | 55.87B | |
| -0.58% | -3.78% | +1.08% | -8.12% | 40.61B | |
| +1.81% | +4.28% | +3.99% | - | 38.48B | |
| +0.35% | +0.35% | +2.69% | +14.26% | 36.66B | |
| -1.13% | -1.87% | -25.56% | -37.14% | 33.9B | |
| Average | -0.00% | -1.28% | -1.48% | +16.47% | 96.7B | |
| Weighted average by Cap. | -0.21% | -1.57% | +0.85% | +31.56% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.03B 5.13B 4.79B 4.49B 8.31B 544B 9.05B 55.81B 21.69B 257B 22.63B 22.15B 936B | 6.61B 5.63B 5.25B 4.93B 9.12B 597B 9.92B 61.22B 23.79B 282B 24.82B 24.3B 1,027B |
| Net income | 1.34B 1.14B 1.06B 999M 1.85B 121B 2.01B 12.4B 4.82B 57.11B 5.03B 4.92B 208B | 1.58B 1.34B 1.25B 1.17B 2.17B 142B 2.36B 14.58B 5.67B 67.14B 5.91B 5.79B 245B |
| Net Debt | -3.29B -2.8B -2.61B -2.45B -4.53B -297B -4.94B -30.45B -11.83B -140B -12.35B -12.09B -511B | -4.45B -3.79B -3.54B -3.32B -6.14B -402B -6.68B -41.22B -16.01B -190B -16.71B -16.36B -691B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 84.01 $ | +0.11% | 1,184,184 |
| 10/12/25 | 83.92 $ | +0.77% | 2,898,619 |
| 09/12/25 | 83.28 $ | -1.23% | 2,412,585 |
| 08/12/25 | 84.32 $ | -2.17% | 3,579,252 |
| 05/12/25 | 86.19 $ | +0.48% | 3,461,311 |
Delayed Quote Nyse, December 12, 2025 at 04:33 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition